logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Hypotension Orthostatic

    FiltersReset Filters
    11 results

    • droxidopa

      (Droxidopa)
      CivicaScript LLC
      Usage: Droxidopa capsules are indicated for treating orthostatic dizziness and lightheadedness in adults with symptomatic neurogenic orthostatic hypotension due to conditions like Parkinson's disease, multiple system atrophy, and non-diabetic autonomic neuropathy. Effectiveness beyond two weeks has not been established and should be periodically assessed.

    • droxidopa

      (Droxidopa)
      MSN LABORATORIES PRIVATE LIMITED
      Usage: Droxidopa capsules are indicated for treating orthostatic dizziness and lightheadedness in adults with symptomatic neurogenic orthostatic hypotension due to conditions like Parkinson's disease, multiple system atrophy, dopamine beta-hydroxylase deficiency, and non-diabetic autonomic neuropathy. Effectiveness beyond 2 weeks has not been established.

    • droxidopa

      (droxidopa)
      Sun Pharmaceutical Industries, Inc.
      Usage: Droxidopa capsules are indicated for treating orthostatic dizziness and lightheadedness in adult patients with symptomatic neurogenic orthostatic hypotension due to conditions like Parkinson's disease, multiple system atrophy, dopamine beta-hydroxylase deficiency, and non-diabetic autonomic neuropathy. Effectiveness beyond 2 weeks is not established.

    • droxidopa

      (Droxidopa)
      Novadoz Pharmaceuticals LLC
      Usage: Droxidopa capsules are indicated for treating orthostatic dizziness and lightheadedness in adults with symptomatic neurogenic orthostatic hypotension due to conditions like Parkinson's disease, multiple system atrophy, dopamine beta-hydroxylase deficiency, and non-diabetic autonomic neuropathy. Long-term effectiveness is not established and should be periodically reassessed.

    • droxidopa

      (Droxidopa)
      Ajanta Pharma USA Inc.
      Usage: Droxidopa capsules are indicated for treating orthostatic dizziness, lightheadedness, or a pre-blackout sensation in adults with symptomatic neurogenic orthostatic hypotension due to conditions like Parkinson's disease, multiple system atrophy, and others. Effectiveness beyond 2 weeks has not been established.

    • midodrine hydrochloride

      (Midodrine Hydrochloride)
      Drug Ocean LLC
      Usage: Midodrine hydrochloride tablets are indicated for treating symptomatic orthostatic hypotension in patients significantly impaired despite standard care. It elevates standing systolic blood pressure, but established clinical benefits remain unverified. Treatment should continue only if patients report significant symptomatic improvement after initiation.

    • midodrine hydrochloride

      (Midodrine Hydrochloride)
      Rising Pharmaceuticals, Inc.
      Usage: Midodrine hydrochloride tablets are indicated for treating symptomatic orthostatic hypotension in patients whose lives are significantly impaired despite standard care. Its use is based on effects on standing blood pressure, though clinical benefits have yet to be established. Continued use requires significant symptomatic improvement.

    • midodrine hydrochloride

      (MIDODRINE HYDROCHLORIDE)
      Alembic Pharmaceuticals Inc.
      Usage: Midodrine hydrochloride tablets are indicated for treating symptomatic orthostatic hypotension in patients whose condition significantly impairs their daily life despite standard care. Although it increases standing systolic blood pressure, clinical benefits have not yet been established and require further investigation. Treatment should continue only with reported symptomatic improvement.

    • midodrine hydrochloride

      (Midodrine Hydrochloride)
      Par Pharmaceutical, Inc.
      Usage: Midodrine hydrochloride tablets are indicated for treating symptomatic orthostatic hypotension in patients whose lives are significantly impaired despite standard care. While it may improve standing blood pressure, its clinical benefits are not yet established and further trials are ongoing. Treatment should continue only with reported symptomatic improvement.

    • midodrine hydrochloride

      (Midodrine Hydrochloride)
      Umasuto, LLC
      Usage: Midodrine hydrochloride tablets are indicated for treating symptomatic orthostatic hypotension in patients significantly impaired despite standard care. It increases standing systolic blood pressure, but clinical benefits related to daily activities have not been established. Ongoing trials aim to confirm these potential benefits.